Ortega-Paz, L.; Laudani, C.; Sionis, A.; Vidal-Cales, P.; Arevalos, V.; Andrea, R.; Morr, C.I.; De Diego, O.; Ortega, E.; Jimenez-Trinidad, F.-R.;
et al. Effect of DAPAgliflozin on Myocardial Fibrosis and Ventricular Function in Patients with ST-Segment Elevation Myocardial Infarction—DAPA-STEMI Trial. J. Cardiovasc. Dev. Dis. 2025, 12, 220.
https://doi.org/10.3390/jcdd12060220
AMA Style
Ortega-Paz L, Laudani C, Sionis A, Vidal-Cales P, Arevalos V, Andrea R, Morr CI, De Diego O, Ortega E, Jimenez-Trinidad F-R,
et al. Effect of DAPAgliflozin on Myocardial Fibrosis and Ventricular Function in Patients with ST-Segment Elevation Myocardial Infarction—DAPA-STEMI Trial. Journal of Cardiovascular Development and Disease. 2025; 12(6):220.
https://doi.org/10.3390/jcdd12060220
Chicago/Turabian Style
Ortega-Paz, Luis, Claudio Laudani, Alessandro Sionis, Pablo Vidal-Cales, Victor Arevalos, Rut Andrea, Carlos Igor Morr, Oriol De Diego, Emilio Ortega, Francisco-Rafael Jimenez-Trinidad,
and et al. 2025. "Effect of DAPAgliflozin on Myocardial Fibrosis and Ventricular Function in Patients with ST-Segment Elevation Myocardial Infarction—DAPA-STEMI Trial" Journal of Cardiovascular Development and Disease 12, no. 6: 220.
https://doi.org/10.3390/jcdd12060220
APA Style
Ortega-Paz, L., Laudani, C., Sionis, A., Vidal-Cales, P., Arevalos, V., Andrea, R., Morr, C. I., De Diego, O., Ortega, E., Jimenez-Trinidad, F.-R., Dantas, A. P., Angiolillo, D. J., Sabaté, M., Ortiz-Pérez, J. T., & Brugaletta, S.
(2025). Effect of DAPAgliflozin on Myocardial Fibrosis and Ventricular Function in Patients with ST-Segment Elevation Myocardial Infarction—DAPA-STEMI Trial. Journal of Cardiovascular Development and Disease, 12(6), 220.
https://doi.org/10.3390/jcdd12060220
